Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Nerve Block

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07673549Not ApplicableNot Yet RecruitingPrimary

Efficacy and Safety of Oral Antiviral Therapy for Idiopathic Trigeminal Neuralgia

NCT03131466Not ApplicableCompletedPrimary

High-voltage Pulsed Radiofrequency on Gasserian Ganglion to Treat Patients With Primary Trigeminal Neuralgia

Showing all 2 trials

Research Network

Common Treatments

  • Nerve Block1
  • Highvoltage Pulsed Radiofrequency1
  • Interventiondrug Carbamazepine Acyclovir1
  • Interventiondrug Carbamazepine1
  • Interventiondrug Carbamazepine Celecoxib1

Active Sponsors

  • Beijing Tiantan Hospital2
  • Beijing Ditan Hospital1
  • Beijing Sanbo Brain Hospital1
  • Beijing Friendship Hospital1

Top Investigators

Activity Timeline